These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6456099)

  • 1. Strain dependency of the transfer of experimental immune insulitis in mice.
    Kiesel U; Kolb H; Freytag G
    Clin Exp Immunol; 1981 Feb; 43(2):430-3. PubMed ID: 6456099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer of experimental autoimmune insulitis by spleen cells in mice.
    Kiesel U; Freytag G; Biener J; Kolb H
    Diabetologia; 1980; 19(6):516-20. PubMed ID: 7007132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic insulitis after partial islet damage by passive insulin antibody transfer.
    Wrede G; Kiesel U; Freytag G; Kolb H
    Horm Metab Res; 1984 Dec; 16 Suppl 1():97-101. PubMed ID: 6398269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulitis as a consequence of immune dysregulation: further evidence.
    Flohr K; Kiesel U; Freytag G; Kolb H
    Clin Exp Immunol; 1983 Sep; 53(3):605-13. PubMed ID: 6352097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
    Herold KC; Baumann E; Vezys V; Buckingham F
    J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immune reactions against pancreatic islets as a consequence of graft versus host disease.
    Kolb H; Freytag G; Kiesel U; Kolb-Bachofen V
    Clin Exp Immunol; 1981 Jan; 43(1):121-7. PubMed ID: 7018756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic-histochemical characterization of inflammatory cells in insulitis induced by multiple subdiabetogenic doses of streptozotocin in C57B1/KsJ mice.
    Schneider E; Wohlrab F; Cossel L
    Biomed Biochim Acta; 1984; 43(5):683-90. PubMed ID: 6236802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
    Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model.
    O'Brien BA; Harmon BV; Cameron DP; Allan DJ
    J Pathol; 1996 Feb; 178(2):176-81. PubMed ID: 8683386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immature syngeneic dendritic cells potentiate tolerance to pancreatic islet allografts depleted of donor dendritic cells in microgravity culture condition.
    Stepkowski SM; Phan T; Zhang H; Bilinski S; Kloc M; Qi Y; Katz SM; Rutzky LP
    Transplantation; 2006 Dec; 82(12):1756-63. PubMed ID: 17198272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis vaccine inhibits immune insulitis induced with streptozotocin.
    Huang SW; Taylor GE
    Clin Exp Immunol; 1982 May; 48(2):375-80. PubMed ID: 6213327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J; Welsh N; Sandler S
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of intrasplenically implanted islets in mice with experimental insulitis and hyperglycemia.
    Sandler S; Andersson A
    Diabetes; 1982 Aug; 31 Suppl 4():78-83. PubMed ID: 6219904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet-specific T cell clones transfer diabetes to nonobese diabetic (NOD) F1 mice.
    Peterson JD; Pike B; McDuffie M; Haskins K
    J Immunol; 1994 Sep; 153(6):2800-6. PubMed ID: 8077683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet pathology in streptozotocin-induced auto-immune diabetic mice: new insights into clinical practice.
    Büyükdevrim AS
    Diabete Metab; 1994; 20(2):87-94. PubMed ID: 7805956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.
    Li H; Kaufman CL; Boggs SS; Johnson PC; Patrene KD; Ildstad ST
    J Immunol; 1996 Jan; 156(1):380-8. PubMed ID: 8598488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prophylactic insulin treatment on the number of ER-MP23+ macrophages in the pancreas of NOD mice. Is the prevention of diabetes based on beta-cell rest?
    Jansen A; Rosmalen JG; Homo-Delarche F; Dardenne M; Drexhage HA
    J Autoimmun; 1996 Jun; 9(3):341-8. PubMed ID: 8816969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
    Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
    J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct.
    Nicoletti F; Di Marco R; Papaccio G; Conget I; Gomis R; Bernardini R; Sims JE; Shoenfeld Y; Bendtzen K
    Eur J Immunol; 2003 Aug; 33(8):2278-86. PubMed ID: 12884303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Young NOD mice show increased diabetes sensitivity to low doses of streptozotocin.
    Reddy S; Chang M; Robinson E
    Ann N Y Acad Sci; 2006 Oct; 1079():109-13. PubMed ID: 17130539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.